Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial - Locke, F L; Ghobadi, A; Jacobson, C A (Lancet Oncol, 2018)
et al.